Recombinant Valine--tRNA ligase (valS), partial

Shipped with Ice Packs
In Stock

Description

Definition and Biological Role

Recombinant Valine-tRNA ligase (ValS), partial, refers to a truncated form of the native enzyme (EC 6.1.1.9) expressed in systems like E. coli or yeast. The enzyme performs the ATP-dependent aminoacylation reaction:

ATP + L-valine + tRNAValAMP + diphosphate + L-valyl-tRNAVal\text{ATP + L-valine + tRNA}^{Val} \rightleftharpoons \text{AMP + diphosphate + L-valyl-tRNA}^{Val}

Partial constructs typically exclude non-essential regions but retain catalytic or substrate-binding domains .

Production Methods

Recombinant ValS is synthesized using diverse platforms:

Host SystemAdvantagesExample Construct
E. coliHigh yield, cost-effectiveUniprot Q8E6S0 (1–884 residues)
YeastEukaryotic post-translational modificationsCusabio CSB-YP814988SMH
BaculovirusSuitable for large, complex proteinsCusabio CSB-BP665865SMG

Liquid formulations are stabilized with 5–50% glycerol, while lyophilized powders ensure long-term storage .

Functional Insights from Research

  • Aminoacylation Mechanism: The enzyme employs a "double sieve" to discriminate valine from similar amino acids (e.g., threonine). The first sieve excludes larger side chains (e.g., isoleucine), while the second hydrolyzes mischarged Thr-tRNAVal^{Val} via post-transfer editing .

  • Proline Triplet Role: Mutations in the PPP motif (e.g., P41G) reduce tRNA charging efficiency by >90%, underscoring its role in valine-AMP stabilization .

  • EF-P Dependency: Ribosomal stalling at the ValS proline triplet necessitates elongation factor P (EF-P) for efficient translation in vivo .

Applications in Research

ApplicationUse Case
Enzymatic AssaysStudying pre- and post-transfer editing mechanisms
Structural StudiesX-ray crystallography of ValS- tRNAVal^{Val} complexes (e.g., PDB 1GAX)
Diagnostic ToolsPositive control in Western blotting (e.g., Aviva OPCD00357)
Therapeutic DevelopmentInvestigating ValS overexpression in cancer (e.g., myeloma)

Quality Control Parameters

Commercial variants adhere to stringent standards:

ParameterSpecification
Purity>85–90% (SDS-PAGE)
Endotoxin Levels<1.0 EU/μg (LAL assay)
ActivityValidated via ATP-PPi_i exchange assays

Limitations and Future Directions

Partial constructs may lack full-length editing domains, limiting studies on translational fidelity . Future work could optimize expression systems for intact ValS or engineer hyperaccurate mutants for biotechnological applications .

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary based on purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with normal blue ice packs by default. Requesting dry ice will incur extra fees; please contact us in advance.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, and the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you have a specific tag type requirement, please inform us, and we will prioritize developing that tag.
Synonyms
valS; Valine--tRNA ligase; EC 6.1.1.9; Valyl-tRNA synthetase; ValRS
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Thermus thermophilus
Target Names
valS
Uniprot No.

Target Background

Function
Catalyzes the attachment of valine to tRNA(Val). ValRS has a 'posttransfer' editing activity to hydrolyze mischarged Thr-tRNA(Val) to prevent errors caused by accommodating structurally similar amino acids like threonine.
Protein Families
Class-I aminoacyl-tRNA synthetase family, ValS type 1 subfamily
Subcellular Location
Cytoplasm.

Q&A

What is the fundamental function of Valine-tRNA ligase (ValS)?

ValS is responsible for catalyzing the attachment of valine to its cognate tRNA^Val in a two-step process. First, valine is activated with ATP to form Val-AMP (aminoacyl-adenylate), releasing pyrophosphate. Second, the activated valine is transferred to tRNA^Val, forming Val-tRNA^Val with the concomitant release of AMP . This charged tRNA then participates in protein synthesis by delivering valine to the ribosome, ensuring accurate translation of the genetic code.

What is the significance of the conserved proline triplet in ValS?

The proline triplet in ValS represents the only polyproline stretch that is invariant across all domains of life . This remarkable conservation suggests its critical importance to ValS function. Experimental evidence demonstrates that mutations in this proline triplet dramatically reduce the efficiency of tRNA charging activity. When any of the prolines are replaced with glycine (creating ValS-GPP, -PGP, -PPG, or -GGG mutants), the enzyme's ability to charge tRNA^Val with valine is significantly compromised . This conservation likely reflects an essential structural or functional role in the enzyme's catalytic mechanism.

How does ValS discriminate between valine and structurally similar amino acids?

ValS faces challenges in discriminating between valine and structurally similar amino acids, particularly threonine . To minimize errors in aminoacylation and translation, ValS employs a proofreading (editing) mechanism that is dependent on the presence of cognate tRNA^Val . This editing occurs at a site functionally distinct from the aminoacylation site. When non-cognate amino acids like threonine are mistakenly activated and transferred to tRNA^Val, the editing domain of ValS can deacylate the mischarged Thr-tRNA^Val . This two-tier quality control system significantly reduces the incorporation of incorrect amino acids during protein synthesis.

What are the specific tRNA^Val determinants required for the editing function of ValS?

The editing function of ValS requires specific structural elements in tRNA^Val that are partially distinct from those required for aminoacylation. The universally conserved 3'-terminal adenosine (A76) is absolutely essential for triggering the editing reaction . tRNA^Val variants with any base substitution at position 76 fail to stimulate ATP hydrolysis and become susceptible to misacylation with non-cognate amino acids like threonine .

While mutations in the acceptor stem of tRNA^Val affect both aminoacylation and editing functions, the effects are not always parallel. For instance, introducing wobble base pairs (like G4:U69) in the acceptor helix significantly reduces editing activity (6-fold reduction compared to wild-type) . The variable pocket formed by D- and T-loops also influences editing efficiency, with mutations in G45 reducing editing capacity by 40-50% . This differential recognition of tRNA^Val at the aminoacylation and editing sites represents a sophisticated mechanism for quality control in protein synthesis.

How does the dependence of ValS expression on EF-P affect experimental approaches with recombinant ValS?

The expression of ValS is strictly dependent on the presence of active Elongation Factor P (EF-P) both in vivo and in vitro . When EF-P is absent, translation stalls at the conserved proline triplet, specifically with the second proline codon positioned in the ribosomal P-site . This dependency creates a significant experimental consideration: any recombinant expression system for ValS must include functional EF-P to achieve full-length protein production. Without EF-P, translation yields only a ~25 kDa truncated product (a ~5 kDa peptide still attached to the ~20 kDa tRNA) . Researchers need to ensure their expression systems account for this dependency to obtain functional recombinant ValS for structural or biochemical studies.

How do mutations in the proline triplet affect the ATP utilization patterns of ValS?

Mutations in the conserved proline triplet of ValS not only reduce tRNA charging efficiency but also fundamentally alter the enzyme's interaction with ATP. Wild-type ValS converts ATP to AMP only in the presence of tRNA^Val and amino acid substrate, reflecting the normal catalytic pathway . In contrast, ValS mutants with altered proline triplets (ValS-GPP, -PGP, and -PPG) exhibit aberrant ATP hydrolysis patterns, converting large amounts of ATP to ADP in a reaction that is independent of tRNA^Val or amino acid substrate .

This non-productive ATP hydrolysis represents a significant alteration in the enzyme's catalytic behavior and suggests that the proline triplet plays a critical role in maintaining proper active site architecture and substrate coordination. When designing experiments with recombinant ValS variants, researchers should account for this altered ATP utilization pattern, which could impact enzyme kinetics measurements and biochemical assays.

What are the optimal experimental designs for studying the dual functions of ValS?

For ValS studies, key factors to include in such designs would be:

  • Mutations in the proline triplet region

  • Variations in tRNA^Val structure

  • Presence/absence of EF-P

  • Concentrations of different amino acid substrates

  • ATP/ADP/AMP ratios

  • Temperature and pH variations

  • Presence of different divalent metal ions

  • Time points for reaction progression

Using a half-fraction design would reduce the required experiments to 128 runs while still providing valuable information about main effects and two-factor interactions . This approach is particularly valuable for initial screening to identify the most significant factors affecting ValS function.

What methodologies are most effective for assessing ValS editing activity?

Several complementary approaches provide comprehensive assessment of ValS editing activity:

  • ATP Hydrolysis Assays: Monitoring the conversion of [γ-32P]-ATP to inorganic phosphate (Pi) using thin-layer chromatography (TLC) allows direct visualization of editing-associated ATP consumption . This assay should include controls with pyrophosphatase to distinguish between aminoacylation-related and editing-related ATP hydrolysis.

  • Mischarging Assays: Using [14C]-threonine to monitor the formation of mischarged Thr-tRNA^Val provides a direct measure of editing efficiency . The rate of Thr-tRNA^Val formation will be higher when the editing function is compromised.

  • Toeprinting Analysis: This technique precisely identifies where ribosomes stall during ValS translation and can confirm the position of translational pauses at the proline triplet . It's particularly useful when studying the EF-P dependency of ValS expression.

  • Comparative Mutation Analysis: Systematically comparing the effects of mutations on both aminoacylation and editing activities reveals the distinct structural requirements for each function . The table below summarizes key findings from such analyses:

tRNA^Val VariantAminoacylation Activity (%)Editing Activity (%)
Wild-type100100
A76 mutantsVariable<5
G75 mutantReduced<5
G4:U69 mutantSignificantly reduced~17
U4:G69 mutantModerately reduced~45
G45 to U45/A4550-6050-60

How should researchers interpret conflicting data between aminoacylation and editing assays?

When aminoacylation and editing assay results diverge, researchers should consider several potential explanations:

  • Differential recognition mechanisms: The 3'-terminus of tRNA^Val is recognized differently at the aminoacylation and editing sites . For example, tRNA^Val variants with pyrimidines (C or U) replacing the normal 3'-terminal adenine remain active in accepting valine but fail to stimulate editing activity .

  • Temporal sequence effects: Most editing by ValS likely involves prior charging of tRNA, with misacylated tRNA serving as a transient intermediate in the editing reaction . Mutations that severely impair aminoacylation might prevent formation of this intermediate, making it difficult to observe editing defects.

  • Structural perturbations: Some mutations may cause subtle conformational changes that differentially affect the spatially distinct aminoacylation and editing sites. When analyzing such data, researchers should consider the three-dimensional relationships between these sites.

  • Reaction conditions: Editing and aminoacylation may have different optimal conditions (temperature, pH, salt concentration). Ensure that assay conditions are optimized for the specific activity being measured.

A comprehensive approach includes performing multiple types of assays (ATP hydrolysis, mischarging, direct deacylation) under varied conditions to develop a complete mechanistic picture.

What statistical approaches are most appropriate for analyzing ValS functional data?

When analyzing data from fractional factorial experiments on ValS function, several statistical approaches are essential:

  • Effects analysis: Calculate main effects and interaction effects to identify which factors significantly influence ValS activity . This approach is particularly valuable in unreplicated fractional factorial designs where traditional ANOVA cannot be applied.

  • Normal probability plots: Use these to distinguish significant effects from random noise in unreplicated designs . Effects that deviate from the normal probability line represent factors with genuine influence on ValS function.

  • Fold-over designs: When ambiguity arises due to confounding in fractional factorial designs, fold-over designs can help resolve which factors are truly significant .

  • Regression modeling: Develop predictive models of ValS activity based on experimental variables, incorporating both main effects and significant interactions.

  • Time-course analysis: For kinetic data on ValS activity, consider time-series analysis approaches that account for the temporal relationship between measurements.

What are the key challenges in producing functional recombinant ValS?

Producing functional recombinant ValS presents several challenges:

  • EF-P dependency: Expression of full-length ValS is strictly dependent on active EF-P . Without it, translation stalls at the conserved proline triplet. Expression systems must therefore include functional EF-P, which may require co-expression strategies or specialized cell lines.

  • Structural integrity: The conserved proline triplet is critical for proper ValS function. Even single proline-to-glycine substitutions significantly reduce charging activity and cause aberrant ATP hydrolysis . Expression conditions must preserve the native structure of this region.

  • Dual activity measurement: Assessing both aminoacylation and editing functions requires distinct assays, complicating functional characterization .

  • tRNA requirements: Full functional assessment requires native tRNA^Val, which may need to be co-expressed or added exogenously to assay systems .

  • Species-specific differences: ValS from different organisms may have distinct properties and dependencies, requiring tailored expression and purification protocols.

What new methodological approaches might advance research on the editing mechanism of ValS?

Several emerging methodologies hold promise for deeper insights into ValS editing mechanisms:

  • Time-resolved structural studies: Capturing the conformational changes during the transition from aminoacylation to editing could reveal critical mechanistic details. Cryo-electron microscopy with multiple state captures or time-resolved X-ray crystallography would be valuable approaches.

  • Single-molecule fluorescence: Monitoring individual ValS molecules during aminoacylation and editing could reveal the temporal relationship between these processes and detect transient intermediates.

  • Hydrogen-deuterium exchange mass spectrometry: This technique could identify regions of ValS that undergo conformational changes during editing, helping map the communication between aminoacylation and editing sites.

  • Computational modeling: Molecular dynamics simulations could predict how tRNA^Val elements interact with both sites and how information is transmitted between them.

  • Deep mutational scanning: Systematically testing thousands of ValS variants could comprehensively map the sequence-function relationships governing both aminoacylation and editing activities.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.